Magellan Healthcare Expands Real-World Impact of DCBT, While Improving Member Access & Engagement

Magellan Healthcare (Magellan) has provided nationally recognized behavioral health solutions for employers, health plans, and state and federal agencies for over 50 years. From employee assistance programs to Medicaid programs for individuals with serious mental illness, Magellan’s evidence-based solutions help over 22 million members worldwide live healthy, vibrant lives.

Access to behavioral healthcare services is a growing problem in the U.S.1 Since 1994, Magellan has addressed this issue with its SAMHSA-endorsed digital cognitive behavioral therapy (DCBT) modules that deliver impressive outcomes. Published randomized controlled trials have shown DCBT to be equivalent to usual therapy in mild to moderate anxiety and depression. To advance the technology on which the DCBT modules were built, Magellan collaborated with NeuroFlow, a behavioral health technology company that rebuilt Magellan’s programs in a single experience that begins with assessments, directs the user to appropriate DCBT modules for their conditions, and provides additional self-help tools and crisis support. Magellan’s new Digital Emotional Wellbeing program, now powered by NeuroFlow, improves engagement while maintaining the clinical excellence of previous DCBT versions. Magellan, an NCQA-certified Managed Behavioral Healthcare Organization, uses these evidence-based, clinically effective DCBT programs to enhance availability of care for members.

Read the full case study here.

Ellen Harvey is the Senior Content Marketing Manager at NeuroFlow. She has over nine years of experience writing about technology and innovation for business leaders. At NeuroFlow, she writes about prominent trends in behavioral health and illustrates how NeuroFlow's technology helps healthcare, payor, and government organizations improve the well-being of their constituents.

Enter your keyword